{"id":"W3171364159","doi":"10.1200/jco.2021.39.15_suppl.6073","title":"Selpercatinib efficacy and safety in patients with <i>RET</i>-altered thyroid cancer: A clinical trial update.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Eli Lilly and Company","keywords":"Medicine; Medullary thyroid cancer; Vandetanib; Internal medicine; Cabozantinib; Thyroid cancer; Clinical endpoint; Population; Adverse effect; Oncology; Cancer; Clinical trial; Thyroid","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002599147,0.0004060802,0.001665259,0.0004792767,0.0001653244,0.001210181,0.000613977,0.0006790597,0.002889128],"category_scores_gemma":[0.002581476,0.0001797335,0.001035422,0.0009561258,0.000259053,0.0008444565,0.0002744774,0.001288563,0.0005974413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009280328,"about_ca_system_score_gemma":0.001002668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009080046,"about_ca_topic_score_gemma":0.003990866,"domain_scores_codex":[0.9995541,0.0001524168,0.00008383009,0.00005088923,0.0001114149,0.00004732143],"domain_scores_gemma":[0.998632,0.0005303372,0.0003917617,0.00005598964,0.0002834725,0.0001063859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03270731,0.0007558507,0.008198922,0.01226457,0.00309477,0.0001707631,0.0001579041,0.001400178,0.01060939,0.001092488,0.05396673,0.8755811],"study_design_scores_gemma":[0.08410667,0.05506108,0.103518,0.01003769,0.02185591,0.00421891,0.0003624049,0.004637592,0.01269332,0.005136152,0.6981265,0.0002456995],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2220419,0.7236596,0.001848247,0.0123999,0.000900172,0.001556233,0.01138025,0.0005134835,0.02570026],"genre_scores_gemma":[0.6036826,0.3489485,0.004112062,0.01340583,0.001687543,0.001974036,0.0200485,0.0001612263,0.00597959],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002889128,"threshold_uncertainty_score":0.01374578,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09458236338123119,"score_gpt":0.4656421353871166,"score_spread":0.3710597720058854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}